Bayer subsidiary doses first patient with Parkinson’s disease cell therapy
German pharma company announces progress in its ‘two-pronged’ cell and gene therapy approach to Parkinson’s disease
Read More
Tag: AskBio
Bayer to acquire cell and gene therapy specialist AskBio
Deal could be worth up to $4bn dependent on success milestones
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
